Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS)
CNY 27.9
(0.04%)
CNY 27.9
(0.04%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2.82 Billion CNY | 30.04% |
| 2022 | 2.17 Billion CNY | 26.27% |
| 2021 | 1.71 Billion CNY | 34.6% |
| 2020 | 1.27 Billion CNY | -21.3% |
| 2019 | 1.62 Billion CNY | -3.84% |
| 2018 | 1.68 Billion CNY | 37.96% |
| 2017 | 1.22 Billion CNY | 30.97% |
| 2016 | 934.18 Million CNY | 36.06% |
| 2015 | 686.57 Million CNY | 32.19% |
| 2014 | 519.39 Million CNY | 28.97% |
| 2013 | 402.72 Million CNY | 1262.17% |
| 2012 | -34.65 Million CNY | -537.73% |
| 2011 | 7.91 Million CNY | -6.45% |
| 2010 | 8.46 Million CNY | 9.78% |
| 2009 | 7.7 Million CNY | -8.01% |
| 2008 | 8.37 Million CNY | -22.95% |
| 2007 | 10.87 Million CNY | 21.71% |
| 2006 | 8.93 Million CNY | 5.97% |
| 2005 | 8.43 Million CNY | 13.52% |
| 2004 | 7.42 Million CNY | 0.34% |
| 2003 | 7.4 Million CNY | -46.71% |
| 2002 | 13.89 Million CNY | -21.52% |
| 2001 | 17.7 Million CNY | 21.69% |
| 2000 | 14.54 Million CNY | -14.54% |
| 1999 | 17.02 Million CNY | 60.17% |
| 1998 | 10.62 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 493.04 Million CNY | -41.67% |
| 2024 Q1 | 845.26 Million CNY | -3.8% |
| 2024 Q3 | 564.52 Million CNY | 14.5% |
| 2023 Q1 | 676.75 Million CNY | 16.96% |
| 2023 FY | 2.82 Billion CNY | 30.04% |
| 2023 Q4 | 878.62 Million CNY | 45.39% |
| 2023 Q3 | 604.31 Million CNY | -8.86% |
| 2023 Q2 | 663.08 Million CNY | -2.02% |
| 2022 Q4 | 578.64 Million CNY | 0.36% |
| 2022 Q2 | 434.38 Million CNY | -25.26% |
| 2022 Q1 | 581.18 Million CNY | 29.96% |
| 2022 FY | 2.17 Billion CNY | 26.27% |
| 2022 Q3 | 576.54 Million CNY | 32.73% |
| 2021 Q2 | 414.74 Million CNY | -5.55% |
| 2021 Q1 | 439.09 Million CNY | 38.23% |
| 2021 Q4 | 447.2 Million CNY | 6.95% |
| 2021 Q3 | 418.12 Million CNY | 0.81% |
| 2021 FY | 1.71 Billion CNY | 34.6% |
| 2020 Q4 | 317.66 Million CNY | 15.6% |
| 2020 FY | 1.27 Billion CNY | -21.3% |
| 2020 Q2 | 220.56 Million CNY | -52.48% |
| 2020 Q3 | 274.8 Million CNY | 24.59% |
| 2020 Q1 | 464.17 Million CNY | 46.24% |
| 2019 Q4 | 317.41 Million CNY | -7.17% |
| 2019 Q1 | 510.17 Million CNY | 34.58% |
| 2019 Q2 | 453.47 Million CNY | -11.11% |
| 2019 Q3 | 341.91 Million CNY | -24.6% |
| 2019 FY | 1.62 Billion CNY | -3.84% |
| 2018 Q2 | 375.68 Million CNY | -19.53% |
| 2018 Q4 | 379.09 Million CNY | -18.69% |
| 2018 FY | 1.68 Billion CNY | 37.96% |
| 2018 Q1 | 466.83 Million CNY | 47.66% |
| 2018 Q3 | 466.25 Million CNY | 24.11% |
| 2017 Q2 | 291.1 Million CNY | 0.13% |
| 2017 Q1 | 290.71 Million CNY | 12.67% |
| 2017 FY | 1.22 Billion CNY | 30.97% |
| 2017 Q4 | 316.14 Million CNY | -2.88% |
| 2017 Q3 | 325.5 Million CNY | 11.82% |
| 2016 Q4 | 258 Million CNY | 9.45% |
| 2016 FY | 934.18 Million CNY | 36.06% |
| 2016 Q1 | 209.12 Million CNY | 11.49% |
| 2016 Q3 | 235.74 Million CNY | 1.92% |
| 2016 Q2 | 231.3 Million CNY | 10.61% |
| 2015 Q4 | 187.56 Million CNY | 11.78% |
| 2015 FY | 686.57 Million CNY | 32.19% |
| 2015 Q2 | 171.57 Million CNY | 7.48% |
| 2015 Q3 | 167.8 Million CNY | -2.2% |
| 2015 Q1 | 159.62 Million CNY | 13.47% |
| 2014 Q2 | 129.51 Million CNY | 3.1% |
| 2014 Q3 | 123.58 Million CNY | -4.58% |
| 2014 Q4 | 140.67 Million CNY | 13.83% |
| 2014 FY | 519.39 Million CNY | 28.97% |
| 2014 Q1 | 125.61 Million CNY | -68.77% |
| 2013 Q4 | 402.26 Million CNY | 2099.46% |
| 2013 FY | 402.72 Million CNY | 1262.17% |
| 2013 Q2 | -18.01 Million CNY | -9800.09% |
| 2013 Q1 | 185.73 Thousand CNY | 100.47% |
| 2013 Q3 | 18.28 Million CNY | 201.52% |
| 2012 Q3 | 2.65 Million CNY | 157.88% |
| 2012 Q1 | 902.78 Thousand CNY | 386.78% |
| 2012 Q2 | 1.02 Million CNY | 13.91% |
| 2012 FY | -34.65 Million CNY | -537.73% |
| 2012 Q4 | -39.23 Million CNY | -1579.49% |
| 2011 FY | 7.91 Million CNY | -6.45% |
| 2011 Q1 | 800.46 Thousand CNY | -13.72% |
| 2011 Q2 | 2.56 Million CNY | 220.63% |
| 2011 Q3 | 4.86 Million CNY | 89.53% |
| 2011 Q4 | -314.8 Thousand CNY | -106.47% |
| 2010 Q2 | 3.22 Million CNY | 452.68% |
| 2010 FY | 8.46 Million CNY | 9.78% |
| 2010 Q4 | 927.7 Thousand CNY | -75.08% |
| 2010 Q3 | 3.72 Million CNY | 15.35% |
| 2010 Q1 | 584.01 Thousand CNY | -68.41% |
| 2009 Q1 | 470.51 Thousand CNY | -81.91% |
| 2009 FY | 7.7 Million CNY | -8.01% |
| 2009 Q4 | 1.84 Million CNY | -25.75% |
| 2009 Q3 | 2.49 Million CNY | -14.11% |
| 2009 Q2 | 2.89 Million CNY | 516.16% |
| 2008 Q1 | 383.53 Thousand CNY | -86.5% |
| 2008 Q3 | 896.42 Thousand CNY | -80.08% |
| 2008 FY | 8.37 Million CNY | -22.95% |
| 2008 Q4 | 2.6 Million CNY | 190.08% |
| 2008 Q2 | 4.49 Million CNY | 1073.07% |
| 2007 Q3 | 1.67 Million CNY | -71.31% |
| 2007 Q2 | 5.84 Million CNY | 1043.0% |
| 2007 Q1 | 511.52 Thousand CNY | -57.67% |
| 2007 FY | 10.87 Million CNY | 21.71% |
| 2007 Q4 | 2.84 Million CNY | 69.31% |
| 2006 Q4 | 1.2 Million CNY | -14.17% |
| 2006 Q2 | 5.68 Million CNY | 788.79% |
| 2006 Q1 | 639.08 Thousand CNY | -1.84% |
| 2006 Q3 | 1.4 Million CNY | -75.21% |
| 2006 FY | 8.93 Million CNY | 5.97% |
| 2005 Q2 | 5.05 Million CNY | 759.03% |
| 2005 Q4 | 651.04 Thousand CNY | -69.6% |
| 2005 Q3 | 2.14 Million CNY | -57.61% |
| 2005 FY | 8.43 Million CNY | 13.52% |
| 2005 Q1 | 588.04 Thousand CNY | 277.45% |
| 2004 FY | 7.42 Million CNY | 0.34% |
| 2004 Q1 | 882.53 Thousand CNY | 126.77% |
| 2004 Q3 | 2.83 Million CNY | -30.0% |
| 2004 Q4 | -331.39 Thousand CNY | -111.7% |
| 2004 Q2 | 4.04 Million CNY | 358.34% |
| 2003 Q3 | 2.51 Million CNY | -49.08% |
| 2003 FY | 7.4 Million CNY | -46.71% |
| 2003 Q2 | 4.94 Million CNY | 52.34% |
| 2003 Q1 | 3.24 Million CNY | 1942.17% |
| 2003 Q4 | -3.29 Million CNY | -231.04% |
| 2002 Q3 | 4.87 Million CNY | 37.14% |
| 2002 Q2 | 3.55 Million CNY | -32.96% |
| 2002 FY | 13.89 Million CNY | -21.52% |
| 2002 Q1 | 5.3 Million CNY | 0.0% |
| 2002 Q4 | 158.8 Thousand CNY | -96.74% |
| 2001 FY | 17.7 Million CNY | 21.69% |
| 2000 FY | 14.54 Million CNY | -14.54% |
| 1999 FY | 17.02 Million CNY | 60.17% |
| 1998 FY | 10.62 Million CNY | 0.0% |